Cardinal Health (CAH) stock rose 1.6% after raising FY26 EPS guidance. Q3 earnings topped estimates, but revenue missed and profit declined year-over-year.
Browsing: News
L3Harris (LHX) beats Q1 estimates with $5.74B revenue and $2.72 EPS, raises 2026 outlook, and files confidentially for missile unit IPO.
Mastercard (MA) stock fell 2.1% despite beating Q1 estimates with $4.60 EPS and $8.4B revenue, as operating costs surged 13% with restructuring charges.
ConocoPhillips (COP) stock falls despite beating Q1 earnings estimates as company cuts production outlook and removes Qatar from guidance due to conflict.
Bank of America raises HPE price target to $38, the highest on Wall Street, as Q1 revenue climbs 18% and AI infrastructure demand accelerates significantly.
FuelCell Energy (FCEL) soared 29% to a 52-week high of $13.66 on AI data center demand, but Wall Street maintains a ‘Reduce’ rating with $8.24 target.
Royal Caribbean (RCL) stock surged 8% premarket after beating Q1 earnings expectations, even as the company reduced full-year guidance on fuel costs.
Ford (F) delivered massive Q1 earnings beat with $3.5B profit vs $1.3B expected, but stock fell after initial surge. UBS cuts target to $14 amid concerns.
Reddit (RDDT) Q1 earnings preview: Analysts expect $608M revenue and $0.57 EPS, with ad revenue up 58% but daily active user growth slowing to 16%.
The Trump administration is preventing Anthropic from extending Mythos AI access to 70 more firms, citing security threats and computing resource constraints.
Caterpillar (CAT) stock rises 5% after beating Q1 earnings with $5.54 EPS, $17.4B revenue, and upgraded 2026 guidance. Full details inside.
Merck (MRK) stock jumped 4.8% after Q1 revenue of $16.3B beat estimates. Keytruda grew 12%, Winrevair surged 88%, and full-year guidance was increased.
eBay (EBAY) crushed Q1 estimates with $1.66 EPS and $3.1B revenue, but shares fell on Q2 GMV outlook of $21.3B-$21.7B, below Q1’s $22.2B performance.
Eli Lilly (LLY) stock rises 5% on Q1 earnings beat with $8.55 EPS, $19.8B revenue, and raised full-year guidance. Foundayo launch underwhelms.
Lockheed Martin (LMT) secures $1.13B Army contract for HIMARS rocket launchers serving U.S. forces and allies through April 2028 despite recent stock decline.